These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 19435431

  • 1. Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection.
    Herpers BL, Vlaminckx B, Burkhardt O, Blom H, Biemond-Moeniralam HS, Hornef M, Welte T, Kuijper EJ.
    Clin Infect Dis; 2009 Jun 15; 48(12):1732-5. PubMed ID: 19435431
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model.
    Baines SD, Saxton K, Freeman J, Wilcox MH.
    J Antimicrob Chemother; 2006 Nov 15; 58(5):1062-5. PubMed ID: 17030519
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of Clostridium difficile infection.
    Gerding DN, Muto CA, Owens RC.
    Clin Infect Dis; 2008 Jan 15; 46 Suppl 1():S32-42. PubMed ID: 18177219
    [Abstract] [Full Text] [Related]

  • 10. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.
    Carignan A, Allard C, Pépin J, Cossette B, Nault V, Valiquette L.
    Clin Infect Dis; 2008 Jun 15; 46(12):1838-43. PubMed ID: 18462108
    [Abstract] [Full Text] [Related]

  • 11. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
    Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL.
    J Hosp Infect; 2008 Oct 15; 70(2):142-7. PubMed ID: 18723249
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A case-control study of community-associated Clostridium difficile infection.
    Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN.
    J Antimicrob Chemother; 2008 Aug 15; 62(2):388-96. PubMed ID: 18434341
    [Abstract] [Full Text] [Related]

  • 14. Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature.
    Di Bella S, Nisii C, Petrosillo N.
    Int J Antimicrob Agents; 2015 Jul 15; 46(1):8-12. PubMed ID: 25982915
    [Abstract] [Full Text] [Related]

  • 15. Treatment of Clostridium difficile-associated disease.
    Leffler DA, Lamont JT.
    Gastroenterology; 2009 May 15; 136(6):1899-912. PubMed ID: 19457418
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.
    Theriot CM, Schumacher CA, Bassis CM, Seekatz AM, Young VB.
    Antimicrob Agents Chemother; 2015 Mar 15; 59(3):1596-604. PubMed ID: 25547352
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.